TechWald Next co-leads RapidPulse USD 48 million Series B round

  • Techwald Holding SPA-backed TechWald Next co-led RapidPulse’s oversubscribed Series B round, raising USD 48 million.
  • RapidPulse develops pulsed aspiration catheter technology for acute ischemic stroke thrombectomy, aiming to improve clot removal.
  • Medtronic co-led the financing; S3 Ventures also co-led, with other healthcare investors participating.
  • Proceeds earmarked to complete the TURBO IDE study, expand clinical use at stroke centers, support a potential FDA approval filing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Techwald Holding SPA published the original content used to generate this news brief on July 16, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.